People with visual impairment 
Українською Information on importing to Ukraine of antiviral medicines containing active substances oseltamivir and zanamivir
Опубліковано 07.02.2020 о 16:24
According to the data base of the SMDC and according to the Resolution of the Cabinet of Ministers of Ukraine of 14.09.2005, No. 902 “On approval of the procedure for conducting state control of the quality of medicinal products imported into Ukraine” (hereinafter – Procedure) during the period since 01.09.2019 till 07.02.2020 the following antiviral medicines containing active substance oseltamivir have been submitted for quality control
|
Importer |
Medicine |
Producer |
№ |
Series |
Quantity |
|
Roche Ukraine, LLC |
TAMIFLU capsules |
Hoffmann-La Roch Ltd, Switzerland |
M1065B03 M1062B07 |
10 558 20 572 Total: 31 130
|
|
|
Roche Ukraine, LLC |
TAMIFLU powder |
Hoffmann-La Roch Ltd, Switzerland |
B8060B02 B8064B02 B8062B02 |
500 660 650 Total: 1 810 |
|
|
S PHARMA LLC |
FLUCAP capsules |
Hetero Labs Limited (India) |
Е191848 Е191666А |
9 615 2 565 Total: 12 180 |
|
|
Macleods Pharmaceuticals Ltd |
SELTAVIR capsules |
Macleods Pharmaceuticals Ltd (India) |
BOJ9901А |
25 355 |
All the above mentioned medicines have passed the state quality control in accordance to the Procedure and the Conclusions on quality recognition have been issued.
Meanwhile, according to the SMDC data base, medicines containing active substance zanamivir were not submitted for quality control during the period between 01.09.2019 and 07.02.2020
Sale of imported medicinal products hasn’t been restricted or prohibited by the SMDC during the period between 01.09.2019 and 07.02.2020
If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.
Попередня